{"id":"https://openalex.org/W4388420249","doi":"https://doi.org/10.1080/14787210.2023.2279719","title":"Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-na\u00efve patients infected with HIV: preliminary results from clinical practice","display_name":"Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-na\u00efve patients infected with HIV: preliminary results from clinical practice","publication_year":2023,"publication_date":"2023-11-06","ids":{"openalex":"https://openalex.org/W4388420249","doi":"https://doi.org/10.1080/14787210.2023.2279719","pmid":"https://pubmed.ncbi.nlm.nih.gov/37927079"},"language":"en","primary_location":{"id":"doi:10.1080/14787210.2023.2279719","doi":"https://doi.org/10.1080/14787210.2023.2279719","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14787210.2023.2279719","pdf_url":null,"source":{"id":"https://openalex.org/S185628608","display_name":"Expert Review of Anti-infective Therapy","issn_l":"1478-7210","issn":["1478-7210","1744-8336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anti-infective Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4388420249"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/14787210.2023.2279719","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086451736","display_name":"Lin Gan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Gan","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017453759","display_name":"Xiaoxin Xie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxin Xie","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087483845","display_name":"Yanhua Fu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanhua Fu","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101424015","display_name":"Xiaoyan Yang","orcid":"https://orcid.org/0000-0003-3483-5658","observed_orcids":["https://orcid.org/0000-0003-3483-5658"]},"institutions":[{"id":"https://openalex.org/I149137203","display_name":"Guiyang Medical University","ror":"https://ror.org/035y7a716","country_code":"CN","type":"education","lineage":["https://openalex.org/I149137203"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoyan Yang","raw_affiliation_strings":["School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China","institution_ids":["https://openalex.org/I149137203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100881997","display_name":"Shujing Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149137203","display_name":"Guiyang Medical University","ror":"https://ror.org/035y7a716","country_code":"CN","type":"education","lineage":["https://openalex.org/I149137203"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shujing Ma","raw_affiliation_strings":["School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China","institution_ids":["https://openalex.org/I149137203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103336262","display_name":"Linghong Kong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149137203","display_name":"Guiyang Medical University","ror":"https://ror.org/035y7a716","country_code":"CN","type":"education","lineage":["https://openalex.org/I149137203"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Linghong Kong","raw_affiliation_strings":["School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China","institution_ids":["https://openalex.org/I149137203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102178510","display_name":"Chunli Song","orcid":"https://orcid.org/0009-0006-2019-9370","observed_orcids":["https://orcid.org/0009-0006-2019-9370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunli Song","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056155821","display_name":"Yebing Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yebing Song","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tingting Ren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tingting Ren","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064541287","display_name":"Hai Long","orcid":"https://orcid.org/0000-0001-5744-5623","observed_orcids":["https://orcid.org/0000-0001-5744-5623"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hai Long","raw_affiliation_strings":["Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infection disease department of Guiyang Public Health Clinical Center, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5064541287"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.1558,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.94927328,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"22","issue":"10","first_page":"877","last_page":"884"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7070000171661377},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/bictegravir","display_name":"bictegravir","score":0.8970000147819519},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.9120000004768372},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.652999997138977},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7260000109672546},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.625},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.5329999923706055},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.5820000171661377},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.8265807628631592},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.7997065782546997},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.7830794453620911},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7757891416549683},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.6998847723007202},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5641329288482666},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5329488515853882},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5264618992805481},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.42611101269721985},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.41035887598991394},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34888923168182373},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3339655101299286},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2851254343986511},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1943162977695465},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.12718307971954346},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.09495800733566284}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000099226","descriptor_name":"Dolutegravir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/14787210.2023.2279719","doi":"https://doi.org/10.1080/14787210.2023.2279719","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14787210.2023.2279719","pdf_url":null,"source":{"id":"https://openalex.org/S185628608","display_name":"Expert Review of Anti-infective Therapy","issn_l":"1478-7210","issn":["1478-7210","1744-8336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anti-infective Therapy","raw_type":"journal-article"},{"id":"pmid:37927079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37927079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of anti-infective therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14787210.2023.2279719","doi":"https://doi.org/10.1080/14787210.2023.2279719","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14787210.2023.2279719","pdf_url":null,"source":{"id":"https://openalex.org/S185628608","display_name":"Expert Review of Anti-infective Therapy","issn_l":"1478-7210","issn":["1478-7210","1744-8336"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Anti-infective Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G4237953953","display_name":null,"funder_award_id":"Qian Kehe support [2021] 055","funder_id":"https://openalex.org/F4320322272","funder_display_name":"Guizhou Science and Technology Department"}],"funders":[{"id":"https://openalex.org/F4320322272","display_name":"Guizhou Science and Technology Department","ror":"https://ror.org/00kwnh405"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1819142816","https://openalex.org/W1998353416","https://openalex.org/W2161992903","https://openalex.org/W2169319632","https://openalex.org/W2294845764","https://openalex.org/W2591654352","https://openalex.org/W2752494178","https://openalex.org/W2753489952","https://openalex.org/W2762573664","https://openalex.org/W2783853360","https://openalex.org/W2883577153","https://openalex.org/W2899935160","https://openalex.org/W2979917028","https://openalex.org/W3000709627","https://openalex.org/W3033333369","https://openalex.org/W3042726352","https://openalex.org/W3091955100","https://openalex.org/W3092287618","https://openalex.org/W3094222155","https://openalex.org/W3097377154","https://openalex.org/W3130124799","https://openalex.org/W3193841694","https://openalex.org/W4207018194","https://openalex.org/W4214495631","https://openalex.org/W4220694178"],"related_works":["https://openalex.org/W4388229931","https://openalex.org/W7203873066","https://openalex.org/W4400454284","https://openalex.org/W4403927837","https://openalex.org/W7160191444","https://openalex.org/W7155414454","https://openalex.org/W7122839119","https://openalex.org/W4406145634","https://openalex.org/W3111973746","https://openalex.org/W4416308232"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"efficacy":[2],"and":[3,9,29,34,70,111,131],"safety":[4,35],"of":[5,19,36,46,62,75,93,117,166],"dolutegravir+lamivudine":[6],"(DTG":[7],"+3TC)":[8],"bictegravir/emtricitabine/tenofovir":[10],"alafenamide":[11],"(BIC/FTC/TAF)":[12],"have":[13],"been":[14],"demonstrated":[15],"in":[16,42,107,127,148,155],"clinical":[17],"trials":[18],"treatment-na\u00efve":[20],"therapy.":[21],"However,":[22],"real-life":[23],"data":[24],"are":[25],"lacking.":[26],"We":[27,56],"investigated":[28],"compared":[30],"the":[31,72,91,164],"virological":[32,156],"outcomes":[33],"DTG":[37,76],"+":[38,77],"3TC":[39,78],"with":[40,49,152],"BIC/FTC/TAF":[41,80,135,159],"an":[43],"adult":[44],"cohort":[45,60],"people":[47],"living":[48],"HIV":[50],"(PLWH).":[51],"RESEARCH":[52],"DESIGN":[53],"AND":[54],"METHODS:":[55],"performed":[57],"a":[58],"retrospective":[59],"analysis":[61],"PLWH":[63],"who":[64],"were":[65,119],"na\u00efve":[66],"to":[67,84,95,137,163,174],"antiretroviral":[68,73,149],"therapy":[69],"initiated":[71],"regimen":[74],"or":[79],"from":[81],"January":[82],"2020":[83],"March":[85],"2022.":[86],"Treatment":[87],"effectiveness,":[88],"defined":[89],"as":[90],"capability":[92],"treatment":[94,118],"achieve":[96],"viral":[97],"suppression":[98],"(viral":[99],"load":[100],"<":[101],"50":[102],"copies/mL),":[103],"was":[104],"analyzed.":[105],"Changes":[106],"immunology,":[108,128],"metabolism,":[109,129],"liver":[110,130],"renal":[112,132],"function":[113],"after":[114],"48":[115],"weeks":[116],"evaluated.":[120],"RESULTS:":[121],"=":[122],"0.3).":[123],"No":[124],"differences":[125,154],"existed":[126],"function;":[133],"however,":[134,158],"led":[136],"greater":[138],"weight":[139,167],"gain.":[140],"CONCLUSIONS:":[141],"Both":[142],"optimization":[143],"strategies":[144],"showed":[145],"high":[146],"tolerability":[147],"therapy-na\u00efve":[150],"patients,":[151],"no":[153],"efficacy;":[157],"may":[160],"be":[161],"related":[162],"risk":[165],"gain":[168],"risk.":[169],"Further":[170],"research":[171],"is":[172],"required":[173],"evaluate":[175],"this":[176],"problem.":[177]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-11-07T00:00:00"}
